The distinct adipogenic and inflammatory effects of IL-1β on hASCs depending on treatment timing and duration may explain why some previous studies described an anti-adipogenic (and insulin resistance-inducing) effect of IL-1β35,80,81. The gene discussed is IL1B; the disease is Insulin resistance.